Eletriptan Hydrobromide Structural Formula (Image 01)
Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 0378-4288
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 0378-4288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Estimated Probability Of Initial Headache Response Within 2 Hours* (Image 02)
This appears to be a study or research report involving medication dosage in 20 mg strength. Specifically, it mentions "ELETRIFTAN" as a medication, along with a "DOUBLE BUND PLACEBO" and a dosage of 40 mg. However, without additional context or information it is difficult to determine the exact purpose or findings of the study.*
Figure 2: Estimated Probability Of Taking A Second Dose/other Medication Over The 24 Hours Following The First Dose* (Image 03)
Eletriptan Hydrobromide Tablets 20 mg Bottle Label (Image 04)
This is a description of Eletriptan Hydrobromide Tablets with NDC 0378-4287-85. It contains 20mg of eletriptan hydrobromide per film-coated tablet. The usual dosage and prescribing information can be found with the medication. It is recommended to store the medication at 20° to 25°C (68°to 77°F) and keep it out of reach of children. The manufacturer for this medication is Mylan Pharmaceuticals located in Morgantown, WV, USA, and it was made in India. There is also an expiration date printed on the package.*
Eletriptan Hydrobromide Tablets 40 mg Bottle Label (Image 05)
This is a description of Eletriptan Hydrobromide Tablets, with a dosage of 40 mg eletriptan. The medication is only available with a prescription, and it is important to keep it and all medication out of the reach of children. The tablets are manufactured by Mylan Pharmaceuticals and made in India. The code number is NH/DRUGS/ADIDES, and the product has an NDC number of 0378-4288-85. The label includes instructions for storage at a temperature between 68°F and 77°F. The other text appears to be for labeling purposes only and includes a lot number, expiration date, and serial number.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
